(Q37902246)

25 August 2017

1 reference

title

Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

Athina Markou

1

1 reference

25 August 2017

Yu Liang

series ordinal

2

1 reference

25 August 2017

Evi Lianidou

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

18 July 2011

1 reference

Clinical Chemistry and Laboratory Medicine

25 August 2017

1 reference

25 August 2017

49

1 reference

25 August 2017

10

1 reference

25 August 2017

1591-1603

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

25 August 2017

1 reference

Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Prognostic factors in non-small cell lung cancer: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Molecular predictive and prognostic markers in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A biochemical framework for RNA silencing in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Nuclear export of microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs modulate hematopoietic lineage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs regulate brain morphogenesis in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Stem cell division is regulated by the microRNA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

microRNAs join the p53 network--another piece in the tumour-suppression puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

21 January 2018

MicroRNAs as oncogenes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA signature predicts survival and relapse in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miR-126 regulates angiogenic signaling and vascular integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA expression differentiates between primary lung tumors and metastases to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-206 is associated with invasion and metastasis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Characterization of microRNA expression profiles in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Uncovering growth-suppressive MicroRNAs in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Evolution of microRNA expression during human bronchial squamous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Diversity of gene expression in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Serum response factor micromanaging cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Detection of cancer with serum miRNAs on an oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs as therapeutic targets for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MiRNAs as biomarkers and therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

microRNAs and lung cancer: tumors and 22-mers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Upregulation of miR-21 by Ras in vivo and its role in tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

Prognostic gene signatures for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

MicroRNAs in cancer: personalizing diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.661

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.661

1 reference

25 August 2017

1 reference